Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
T cell receptor signaling pathway | R-HSA-983705 | map04660 | lymecycline | 89034 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | lymecycline | 89034 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | lymecycline | 89034 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | lymecycline | 89034 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | lymecycline | 89034 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | lymecycline | 89034 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | lymecycline | 89034 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | lymecycline | 89034 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | lymecycline | 89034 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | talampicillin | 71447 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | talampicillin | 71447 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | talampicillin | 71447 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | talampicillin | 71447 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | talampicillin | 71447 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | talampicillin | 71447 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | talampicillin | 71447 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | ribavirin | 2123 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | ribavirin | 2123 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ribavirin | 2123 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ribavirin | 2123 | drug-path |